| Coverys Reveals 68% of Inpatient Diagnostic Errors Occur on General Medical-Surgical Units |
Globe Newswire |
10/05 |
08:04 |
| FTC Solar Announces Waiver and Amendment to Credit Agreement |
Globe Newswire |
10/05 |
08:01 |
| Syntec Optics (Nasdaq: OPTX) Lands Artemis III Production Orders, Expands Space Portfolio to Moon Missions |
Globe Newswire |
10/05 |
08:00 |
| Trasteel Holding S.A., Through Newly Established Trasteel Magona, Takes Over Operations of La Magona d’Italia Steel Plant in Piombino, Italy |
Globe Newswire |
10/05 |
08:00 |
| Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities |
Globe Newswire |
10/05 |
08:00 |
| Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom |
Globe Newswire |
10/05 |
08:00 |
| Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study |
Globe Newswire |
10/05 |
08:00 |
| Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce |
Globe Newswire |
10/05 |
08:00 |
| OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting |
Globe Newswire |
10/05 |
08:00 |
| CoreCivic Announces 2026 Third Quarter Earnings Release and Conference Call Dates |
Globe Newswire |
10/05 |
08:00 |
| vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D) |
Globe Newswire |
10/05 |
08:00 |
| DFDV Preliminary Q3’26 Estimates Indicate Double-Digit SPS Growth and More Than 100% NAV Per Share Growth In Q3; SOL Treasury Growth Rises to 11% Since August 12 |
Globe Newswire |
10/05 |
08:00 |
| Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026 |
Globe Newswire |
10/05 |
08:00 |
| PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026 |
Globe Newswire |
10/05 |
08:00 |
| MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network |
Globe Newswire |
10/05 |
08:00 |
| Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer |
Globe Newswire |
10/05 |
08:00 |
| Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP) |
Globe Newswire |
10/05 |
08:00 |
| Northern Discovery Metals Completes Fieldwork at the Vent Copper Project |
Globe Newswire |
10/05 |
08:00 |
| Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer |
Globe Newswire |
10/05 |
08:00 |
| Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilling at Cariboo Gold Project |
Globe Newswire |
10/05 |
08:00 |
| VoltaGrid Completes $775 Million Primary Equity Investment and Upsized $800 Million Secondary Equity Investment |
Globe Newswire |
10/05 |
08:00 |
| Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease |
Globe Newswire |
10/05 |
08:00 |
| STMicroelectronics announces status of common share repurchase program |
Globe Newswire |
10/05 |
08:00 |
| Angeion Group Names Lenny Izzo as Managing Director, Corporate Bankruptcy |
Globe Newswire |
10/05 |
08:00 |
| Sofwave to Participate in the Jefferies Private MedTech Virtual Summit |
Globe Newswire |
10/05 |
08:00 |
